Dr. Oskoui: Hydroxychloroquine Has Favorable Data in France, Italy, and China

RUSH TRANSCRIPT Without any ░░░░░░░░ Laura Dr Oskoui my ░░░░░░░░ is people should be ░░░░░░░░ and I know you ░░░░░░░░ all your patience and ░░░░░░░░ of you do but ░░░░░░░░ think people aren t ░░░░░░░░ it when perhaps and ░░░░░░░░ said perhaps it could ░░░░░░░░ benefit them and it ░░░░░░░░ very safe Again be ░░░░░░░░ observation I think that ░░░░░░░░ exactly correct Her experience ░░░░░░░░ my experience The problem ░░░░░░░░ a lot of these ░░░░░░░░ medical centers are trying ░░░░░░░░ force patients in the ░░░░░░░░ trials which they have ░░░░░░░░ make huge amounts of ░░░░░░░░ on Hydroxychloroquine has out ░░░░░░░░ data that is very ░░░░░░░░ in France Italy and ░░░░░░░░ There is a reason ░░░░░░░░ several countries have compensated ░░░░░░░░ entire national stock France ░░░░░░░░ this late March So ░░░░░░░░ think we shouldn t ░░░░░░░░ pharmacists or doctors that ░░░░░░░░ a secondary gain blocking ░░░░░░░░ from working with a ░░░░░░░░ doctor relationship as we ░░░░░░░░ done for decades Laura ░░░░░░░░ Oskoui Dr Lozano George ░░░░░░░░ hospital group or hospital ░░░░░░░░ put out a warning ░░░░░░░░ Hydroxychloroquine citing that New ░░░░░░░░ started that came out ░░░░░░░░ week That was the ░░░░░░░░ stage later stage patients ░░░░░░░░ people would indicate you ░░░░░░░░ t take.